Riskpilot← Back to searchSign inGet full accessGANDDAL LEGESENTER AS
ASActiveOrg 920204392Olabakken 5, 4322 SandnesGeneral medical practice activities · NACE 8621Est. 20185 employees
Revenue 2025
NOK 3,9M
+17% vs 2024
EBITDA margin
5.5%
+770% vs 2024
Equity ratio
27.1%
Financial strength
Net profit 2025
NOK 165K
+363% vs 2024
| Revenue | NOK 3,9M | +17% |
| EBITDA | NOK 218K | +770% |
| Net profit | NOK 165K | +363% |
| Total assets | NOK 890K | +76% |
| Equity | NOK 241K | +214% |
| Employees | 5 | — |
Legal name
GANDDAL LEGESENTER AS
Org number
920204392
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
8. januar 2018
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av legesenter og alt hva som inngår under dette.
Address
Olabakken 5, 4322 Sandnes
Phone
+4751681313
Email
personvern@webmed.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 041 | 3 462 | 3 345 | 3 350 | 3 931 |
| Staff expenses | −1 970 | −1 893 | −1 911 | −2 228 | −2 205 |
| EBITDA | −104 | 393 | 186 | −32 | 218 |
| Depreciation & amort. | −27 | −32 | −36 | −29 | −20 |
| EBIT | −130 | 361 | 150 | −62 | 198 |
| Net financials | −0 | −0 | −0 | −1 | −0 |
| Profit before tax | −131 | 361 | 150 | −63 | 198 |
| Tax | −0 | 13 | 37 | −0 | 33 |
| Net profit | −131 | 348 | 113 | −63 | 165 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 250 | 374 | 537 | 505 | 890 |
| Equity | −322 | 26 | 139 | 77 | 241 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 571 | 348 | 398 | 429 | 649 |
| Total debt | 571 | 348 | 398 | 429 | 649 |
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
20212025
Equity ratio
27.1%
This company
38.2%
Market median
-29% vs market
20212025
Return on equity
68.2%
This company
18.4%
Market median
+271% vs market
20212025
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
20212025
Asset turnover
4.42×
This company
1.12×
Market median
+295% vs market
20212025
Debt / equity
2.69×
This company
0.62×
Market median
-334% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (3) | ||
| Board of Directors | 2018 – 2022 | |
| Board of Directors | 2018 – 2022 | |
| Chairman | 2018 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GANDDAL LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birger Vårdal | Board of Directors | 0 companies |
| Svein Henning Haarr | Board of Directors | 0 companies |
| Christine Lønning Nytveit | Board of Directors | 0 companies |
| Ole Andreas Bjordal | Chairman | 0 companies |
| Anton Höhn | Board of Directors | 0 companies |